BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 25 filers reported holding BIOPHARMX CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $3,000 | 0.0% | 35,000 | +40.0% | 0.00% | – |
Q4 2018 | $3,000 | -70.0% | 25,000 | -54.5% | 0.00% | – |
Q3 2018 | $10,000 | +25.0% | 55,000 | +57.1% | 0.00% | – |
Q2 2018 | $8,000 | +14.3% | 35,000 | +12.9% | 0.00% | – |
Q1 2018 | $7,000 | +250.0% | 31,000 | +47.6% | 0.00% | – |
Q4 2017 | $2,000 | -77.8% | 21,000 | -36.4% | 0.00% | – |
Q3 2017 | $9,000 | -30.8% | 33,000 | +17.9% | 0.00% | – |
Q2 2017 | $13,000 | – | 28,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 16,128,515 | $1,740,000 | 0.22% |
FRG Family Wealth Advisors LLC | 30,000 | $3,000 | 0.00% |
LEVEL FOUR ADVISORY SERVICES, LLC | 66,933 | $7,000 | 0.00% |
Chicago Partners Investment Group LLC | 32,462 | $4,000 | 0.00% |
Virtu Financial LLC | 98,004 | $11,000 | 0.00% |
NORTHERN TRUST CORP | 92,518 | $10,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 1,343,372 | $144,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 25,349 | $3,000 | 0.00% |
OPPENHEIMER & CO INC | 25,000 | $3,000 | 0.00% |